CONFLICT OF INTEREST STATEMENT
A.L.: Honoraria—Sanofi, Trillium Therapeutics, Pfizer, Janssen, Iteos; Research Funding—Bristol Myers Squibb, Pfizer, Janssen; Patent US20150037346A1. R.L.: Advisory Role—Janssen, Bristol Myers Squibb, Amgen, Sanofi, FORUS Therapeutics. M.A.D.: Advisory Role—Amgen, Beigene, Bristol Myers Squibb, Janssen, Takeda. M.C.: Honoraria—Bristol Myers Squibb, Janssen, Sanofi; Advisory Role—Janssen, Sanofi. C.C.‐S.: Honoraria—ADC Therapeutics, AstraZeneca, Bristol Myers Squibb, Incyte, Janssen, Takeda; Advisory Role—ADC Therapeutics, Bristol Myers Squibb, Celgene, Karyopharm Therapeutics, Novartis, Roche, Sanofi. L.K.: Honoraria—AbbVie, Amgen, Celgene, Janssen, Sanofi, Takeda; Advisory Role—Amgen, Celgene, GSK, Janssen, Takeda. J.‐F.C.: Nothing to disclose. P.F.: Honoraria—Celgene; Advisory Role—Bristol Myers Squibb, GlaxoSmithKline, Sanofi. G.P.: Research Funding—Bristol Myers Squibb; Advisory Role—Bristol My ers Squibb, Janssen, Sanofi. A.T.: Honoraria—Astellas, Bayer. L.P.: Nothing to disclose. V.R.: Advisory Role—AstraZeneca, Bristol Myers Squibb, EPZ, Incyte, MSD, nanostring, Pharmamar, Servier. R.R.: Nothing to disclose. A.‐O.A.: Nothing to disclose. N.L.R. is employed by Altran on behalf of Sanofi and may hold stock and/or stock options in the company. L.D., H.v.d.V., and S.M. are employed by Sanofi and may hold stock and/or stock options in the company. L.M. and L.L. are employed by Excelya on behalf of Sanofi and may hold stock and/or stock options in the company. P.M.: Honoraria—AbbVie, Amgen, Celgene, GlaxoSmithKline, Janssen, Sanofi; Advisory Role—AbbVie, Amgen, Celgene, GlaxoSmithKline, Janssen, Sanofi.